不适合移植的大 B 细胞淋巴瘤二线使用 axicabtagene ciloleucel:ALYCANTE 最终分析
Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Characterization of tumor microenvironment and cell interaction patterns in testicular and diffuse large B-cell lymphomas.
Characterization of tumor microenvironment and cell interaction patterns in testicular and diffuse large B-cell lymphomas.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
弥漫性大B细胞淋巴瘤(DLBCL)不同亚组的肿瘤微环境(TME)特征尚未得到充分描述。本研究使用基因表达谱和多重免疫组化,解析生发中心B细胞型(GCB)、活化B细胞型(ABC)及睾丸型(T)DLBCL的TME组成和空间结构。
研究发现,M2样肿瘤相关巨噬细胞(TAM)和细胞毒性肿瘤浸润T细胞(TIL)比例较高,是ABC型DLBCL TME的特征;此外,CD8+ TIL含量高与较好结局相关。相比之下,GCB型DLBCL TME富含CD4+ TIL、调节性TIL,且M1样与M2样TAM比值较高;TAM和颗粒酶B阳性细胞比例较高则与生存较差相关。与GCB亚型相比,ABC型DLBCL中TIL和TAM更频繁地与M2样TAM及细胞毒性TIL相互作用;GCB亚型中,相关相互作用则更多发生于其他TIL及CD4+ TIL。T-DLBCL的TME与ABC型相似,具有较高比例的M2样TAM和细胞毒性细胞,但与非特指型DLBCL相比,检查点阳性TIL较少。细胞毒性TIL也更多与其他TIL和TAM相互作用。在GCB型DLBCL和T-DLBCL中,大量CD163+ TAM与不同TIL相互作用均与不良生存相关;而TIL与TAM、CD4+ TIL与TAM,以及CD4+ TIL与其他TIL相互作用较多,仅在T-DLBCL中与较好结局相关。
综上,数据揭示不同DLBCL类型的TME组成及细胞相互作用存在具有生物学和临床意义的差异。
The tumor microenvironments (TME) of diffuse large B-cell lymphoma (DLBCL) subgroups have remained poorly characterized.
Here, we dissected the composition and spatial organization of the TME in germinal center B-cell (GCB), activated B-cell (ABC), and testicular (T-) DLBCL using gene expression profiling and multiplex immunohistochemistry.
We found that high proportions of M2-like tumor-associated macrophages (TAM) and cytotoxic tumor-infiltrating T cells (TIL) were characteristic of ABC DLBCL TME.
Furthermore, high CD8+ TIL content translated to favorable outcomes. In contrast, GCB DLBCL TME was enriched in CD4+ TIL, regulatory TIL, and a higher M1-like: M2-like TAM ratio, and high proportions of TAM and Granzyme B+ cells associated with worse survival. TIL and TAM interacted more frequently with M2-like TAM and cytotoxic TIL in the ABC DLBCL in contrast to GCB subtype, where the interactions were more abundant with other TIL and CD4+ TIL.
In T-DLBCL, TME resembled that of ABC DLBCL with a higher proportion of M2-like TAM and cytotoxic cells, except that checkpoint-positive TIL were less prominent compared to DLBCL NOS. Cytotoxic TIL also interacted more with TIL and TAM. A large number of CD163+ TAM interactions with distinct TIL translated to unfavorable survival both in GCB DLBCL and T-DLBCL, whereas a high number of interactions between TIL and TAM, CD4+ TIL and TAM, and CD4+ TIL and other TIL were associated with favorable outcomes only in T-DLBCL.
Together, our data demonstrate biologically and clinically relevant differences in the composition of and cellular interactions in the TME between various DLBCL entities.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。